Catalysts for $VERX
101 tracked
Aug 5, 2026
earnings
Vertex, Inc. earnings
Vertex, Inc.
→
May 7, 2026
earnings
Vertex, Inc. earnings
Vertex, Inc.
→
Apr 30, 2026
phase 2 completion
Vertex Pharmaceuticals Inc — VX-993 (Phase II Trial Completion)
VX-993
→
Mar 27, 2026
approval
TRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approval
TRIKAFTA (COPACKAGED)
→
Mar 27, 2026
approval
TRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approval
TRIKAFTA (COPACKAGED)
→
Mar 27, 2026
approval
ALYFTREK (DEUTIVACAFTOR) — FDA approval
(deutivacaftor + tezacaftor + vanzacaftor calcium)
→
Mar 17, 2026
approval
SYMDEKO (COPACKAGED) (IVACAFTOR) — FDA approval
ivacaftor
→
Mar 17, 2026
approval
ORKAMBI (IVACAFTOR) — FDA approval
(ivacaftor + lumacaftor)
→
Mar 17, 2026
approval
KALYDECO (IVACAFTOR) — FDA approval
ivacaftor
→
Mar 17, 2026
approval
KALYDECO (IVACAFTOR) — FDA approval
Vertex, Inc.
→
Mar 17, 2026
approval
ORKAMBI (IVACAFTOR) — FDA approval
(ivacaftor + lumacaftor)
→
Mar 17, 2026
approval
TRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approval
TRIKAFTA (COPACKAGED)
→
Mar 17, 2026
approval
TRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approval
TRIKAFTA (COPACKAGED)
→
Mar 17, 2026
approval
ALYFTREK (DEUTIVACAFTOR) — FDA approval
(deutivacaftor + tezacaftor + vanzacaftor calcium)
→
Jan 23, 2026
approval
JOURNAVX (SUZETRIGINE) — FDA approval
suzetrigine
→
Sep 25, 2025
approval
SYMDEKO (COPACKAGED) (IVACAFTOR) — FDA approval
ivacaftor
→
Sep 25, 2025
approval
ORKAMBI (IVACAFTOR) — FDA approval
(ivacaftor + lumacaftor)
→
Sep 25, 2025
approval
KALYDECO (IVACAFTOR) — FDA approval
ivacaftor
→
Sep 25, 2025
approval
KALYDECO (IVACAFTOR) — FDA approval
Vertex, Inc.
→
Sep 25, 2025
approval
ORKAMBI (IVACAFTOR) — FDA approval
(ivacaftor + lumacaftor)
→
Sep 25, 2025
approval
TRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approval
TRIKAFTA (COPACKAGED)
→
Sep 25, 2025
approval
TRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approval
TRIKAFTA (COPACKAGED)
→
Sep 25, 2025
approval
ALYFTREK (DEUTIVACAFTOR) — FDA approval
(deutivacaftor + tezacaftor + vanzacaftor calcium)
→
May 22, 2025
approval
KALYDECO (IVACAFTOR) — FDA approval
ivacaftor
→
May 22, 2025
approval
KALYDECO (IVACAFTOR) — FDA approval
Vertex, Inc.
→
Jan 30, 2025
approval
JOURNAVX (SUZETRIGINE) — FDA approval
suzetrigine
→
Dec 20, 2024
approval
TRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approval
TRIKAFTA (COPACKAGED)
→
Dec 20, 2024
approval
TRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approval
TRIKAFTA (COPACKAGED)
→
Dec 20, 2024
approval
TRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approval
TRIKAFTA (COPACKAGED)
→
Dec 20, 2024
approval
TRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approval
TRIKAFTA (COPACKAGED)
→